GENE ONLINE|News &
Opinion
Blog

2025-04-24|

Patient Compliance Reaches 97% in Two Treatment Protocol Study Groups

by Mark Chiang
Share To

NEWSFLASH

Patient compliance reached statistically significant levels, with rates up to 97% in both study arms. The study tracked adherence to treatment protocols among participants in two distinct groups. Specifically, researchers observed that individuals across both arms of the study demonstrated high levels of compliance. The findings indicate a notable consistency in patient adherence within each group. The compliance rate reached as high as 97% in both arms.

Newsflash | Powered by GeneOnline AI
Date: April 24, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
R&D
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
LATEST
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top